BBNX
Beta Bionics, Inc. Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$441.60M
P/E Ratio
—
EPS
$-1.81
Beta
—
52W High
$32.71
52W Low
$9.37
50-Day MA
$12.37
200-Day MA
$19.46
Dividend Yield
—
Profit Margin
-73.00%
Forward P/E
—
PEG Ratio
—
About Beta Bionics, Inc. Common Stock
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $100.25M |
| Gross Profit (TTM) | $55.54M |
| EBITDA | $-70.11M |
| Operating Margin | -50.20% |
| Return on Equity | -40.30% |
| Return on Assets | -18.70% |
| Revenue/Share (TTM) | $2.47 |
| Book Value | $6.48 |
| Price-to-Book | 1.53 |
| Price-to-Sales (TTM) | 4.41 |
| EV/Revenue | 2.288 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 57.10% |
| Shares Outstanding | $44.38M |
| Float | $23.50M |
| % Insiders | 2.34% |
| % Institutions | 109.67% |
Analyst Ratings
Consensus ($23.36 target)
1
Strong Buy8
Buy3
HoldData last updated: 4/7/2026